Abstract
Our previous studies show that the depletion of cholesterol or sphingolipids (raft-associated lipids) from receptor-bearing adherent cell lines blocks HIV-1 entry and HIV-1 Env-mediated membrane fusion. Here we have evaluated the mechanism(s) by which these lipids contribute to the HIV-1 Env-mediated membrane fusion. We report the following: (1) GSL depletion from a suspension T lymphocyte cell line (Sup-T1) reduced subsequent fusion with HIV-1IIIB-expressing cells by 70%. (2) Cholesterol depletion from NIH3T3 cells bearing HIV-1 receptors (NIH3T3CD4R5/NIH3T3CD4X4) did not impair subsequent fusion with HeLa cells expressing the corresponding HIV-1 Envs. In contrast GSL depletion from these targets reduced fusion by 50% suggesting that GSL facilitate fusion in different ways. (3) GSL-deficient GM95 cells bearing high receptors fused with HIV-1 Env-expressing cells at 37°C with kinetics similar to that of GSL + NIH3T3 targets. Based on these observations, we propose that the plasma membrane cholesterol is required to maintain the integrity of receptor pools whereas GSLs are involved in stabilizing the coupling of inter-receptor pools.
Similar content being viewed by others
Abbreviations
- CT:
-
cholera toxin
- GSL(s):
-
glycosphingolipid(s)
- SM:
-
Sphingomyelin
- MeβCD:
-
methyl β-cyclodextrin
- HIV-1 Env-gp:
-
human immunodeficiency virus Type-1 Envelope Glycoprotein
- HIV-1:
-
human immunodeficiency virus Type-1
- DRMs:
-
detergent-resistant membrane domains
- Lipid Rafts:
-
dynamic assemblies of lipids and proteins in the plasma membrane of cells enriched in sphingolipids and cholesterol, which are characterized by virtue of their insolubility in Triton X100 at 4°C also termed as detergent resistant membranes (DRM)
References
Dimitrov, D.S.: How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 91, 721–730 (1997)
Gallo, S.A., Finnegan, C.M., Viard, M., Raviv, Y., Dimitrov, A., Rawat, S.S., Puri, A., Durell, S., Blumenthal, R.: The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta. 1614, 36–50 (2003)
Rawat, S.S., Viard, M., Gallo, S.A., Rein, A., Blumenthal, R., Puri, A.: Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol. Membr. Biol. 20, 243–254 (2003)
Bomsel, M.: Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3, 42–47 (1997)
Puri, A., Hug, P., Jernigan, K., Barchi, J., Kim, H.Y., Hamilton, J., Wiels, J., Murray, G.J., Brady, R.O., Blumenthal, R.: The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 95, 14435–14440 (1998)
Hug, P., Lin, H.M., Korte, T., Xiao, X., Dimitrov, D.S., Wang, J.M., Puri, A., Blumenthal, R.: Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74, 6377–6385 (2000)
Fantini, J., Hammache, D., Pieroni, G., Yahi, N.: Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion. Glycoconj. J. 17, 199–204 (2000)
Hammache, D., Yahi, N., Maresca, M., Pieroni, G., Fantini, J.: Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 73, 5244–5248 (1999)
Hammache, D., Pieroni, G., Yahi, N., Delezay, O., Koch, N., Lafont, H., Tamalet, C., Fantini, J.: Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273, 7967–7971 (1998)
Conboy, J.C., McReynolds, K.D., Gervay-Hague, J., Saavedra, S.S.: Gp120 Binds Cooperatively to Several Biologically Relevant Glycosphingolipids: Quantitative Measurements at Equilibrium by Total Internal Reflection Fluorescence Microscopy. Angew. Chem. Int. 39, 2882–2884 (2000)
Manes, S., del Real, G., Lacalle, R.A., Lucas, P., Gomez-Mouton, C., Sanchez-Palomino, S., Delgado, R., Alcami, J., Mira, E., Martinez, A.: Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1, 190–196 (2000)
Liao, Z., Cimakasky, L.M., Hampton, R., Nguyen, D.H., Hildreth, J.E.: Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17, 1009–1019 (2001)
Viard, M., Parolini, I., Sargiacomo, M., Fecchi, K., Ramoni, C., Ablan, S., Ruscetti, F.W., Wang, J.M., Blumenthal, R.: Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells. J. Virol. 76, 11584–11595 (2002)
Ono, A., Freed, E.O.: Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98, 13925–13930 (2001)
Guyader, M., Kiyokawa, E., Abrami, L., Turelli, P., Trono, D.: Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J. Virol. 76, 10356–10364 (2002)
Campbell, S.M., Crowe, S.M., Mak, J., Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16, 2253–2261 (2002)
Rawat, S.S., Eaton, J., Gallo, S.A., Martin, T.D., Ablan, S., Ratnayake, S., Viard, M., KewalRamani, V.N., Wang, J.M., Blumenthal, R., Puri, A.: Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology 318, 55–65 (2004)
Earl, P.L., Koenig, S., Moss, B.: Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65, 31–41 (1991)
Broder, C.C., Berger, E.A.: Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA 92, 9004–9008 (1995)
Garber, M.E., Wei, P., KewalRamani, V.N., Mayall, T.P., Herrmann, C.H., Rice, A.P., Littman, D.R., Jones, K.A.: The interaction between HIV-1 T at and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes. Dev. 12, 3512–3527 (1998)
Smith, S.D., Shatsky, M., Cohen, P.S., Warnke, R., Link, M.P., Glader, B.E.: Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44, 5657–5660 (1984)
Jonak, Z.L., Clark, R.K., Matour, D., Trulli, S., Craig, R., Henri, E., Lee, E.V., Greig, R., Debouck, C.: A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope. AIDS Res. Hum. Retroviruses 9, 23–32 (1993)
Gallo, S.A., Puri, A., Blumenthal, R.: HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry 40, 12231–12236 (2001)
Radin, N.S.: Chemotherapy by slowing glucosphingolipid synthesis. Biochem. Pharmacol. 57, 589–595 (1999)
Ablan, S., Rawat, S.S., Blumenthal, R., Puri, A.: Entry of influenza virus into a glycosphingolipid-deficient mouse skin fibroblast cell line. Arch. Virol. 146, 2227–2238 (2001)
Viard, M., Parolini, I., Sargiacomo, M., Fecchi, K., Ramoni, C., Ablan, S., Ruscetti, F.W., Wang, J.M., Blumenthal, R.: Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells. J. Virol. 76, 11584–11595 (2002)
Puri, A., Paternostre, M., Blumenthal, R.: Lipids in viral fusion. Methods Mol. Biol. 199, 61–81 (2002)
Chan, D.C., Kim, P.S.: HIV entry and its inhibition. Cell 93, 681–684 (1998)
Dimitrov, D.S.: Cell biology of virus entry. Cell 101, 697–702 (2000)
Berger, E.A.: HIV entry and tropism: the chemokine receptor connection. AIDS 11 Suppl A, S3–16 (1997)
Freed, E.O., Delwart, E.L., Buchschacher, G.L.J., Panganiban, A.T.: A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89, 70–74 (1992)
Jones, P.L., Korte, T., Blumenthal, R.: Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273, 404–409 (1998)
Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., Blumenthal, R.: Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140, 315–323 (1998)
Liao, Z., Cimakasky, L.M., Hampton, R., Nguyen, D.H., Hildreth, J.E.: Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17, 1009–1019 (2001)
Puri, A., Rawat, S.S., Lin, H.M., Finnegan, C.M., Mikovits, J., Ruscetti, F.W., Blumenthal, R.: An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells. AIDS 18, 849–858 (2004)
Singer, I.I., Scott, S., Kawka, D.W., Chin, J., Daugherty, B.L., DeMartino, J.A., DiSalvo, J., Gould, S.L., Lineberger, J.E., Malkowitz, L., Miller, M.D., Mitnaul, L., Siciliano, S.J., Staruch, M.J., Williams, H.R., Zweerink, H.J., Springer, M.S.: CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J. Virol. 75, 3779–3790 (2001)
Fantini, J., Hammache, D., Pieroni, G., Yahi, N.: Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion. Glycoconj. J. 17, 199–204 (2000)
Feigenson, G.W., Buboltz, J.T.: Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol. Biophys. J. 80, 2775–2788 (2001)
Hao, M., Mukherjee, S., Maxfield, F.R.: Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc. Natl. Acad. Sci. USA 98, 13072–13077 (2001)
Iyengar, S., Hildreth, J.E., Schwartz, D.H.: Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 72, 5251–5255 (1998)
Simons, K., Ikonen, E.: Functional rafts in cell membranes. Nature 387, 569–572 (1997)
Brown, D.A., London, E.: Functions of lipid rafts in biological membranes. Annu. Rev. Cell. Dev. Biol. 14, 111–136 (1998)
Sorice, M., Parolini, I., Sansolini, T., Garofalo, T., Dolo, V., Sargiacomo, M., Tai, T., Peschle, C., Torrisi, M.R., Pavan, A.: Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid. Res. 38, 969–980 (1997)
Millan, J., Cerny, J., Horejsi, V., Alonso, M.A.: CD4 segregates into specific detergent-resistant T-cell membrane microdomains. Tissue Antigens. 53, 33–40 (1999)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rawat, S.S., Viard, M., Gallo, S.A. et al. Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion. Glycoconj J 23, 189–197 (2006). https://doi.org/10.1007/s10719-006-7924-4
Issue Date:
DOI: https://doi.org/10.1007/s10719-006-7924-4